Skip to main content
Erschienen in: Digestive Diseases and Sciences 12/2021

22.03.2021 | EDITORIAL

Frailty, Thy Diagnosis Is Uncertain: Impact on IBD Readmission and Mortality

verfasst von: Simon J. Hong, Seymour Katz

Erschienen in: Digestive Diseases and Sciences | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Excerpt

The term frailty was first used in 1979 to explain the heterogeneity in mortality of individuals, with its main focus on the decline in fitness and nutritional status associated with aging [1, 2]. Frailty is now understood to be a multisystem dysregulation of homeostatic reserves that can occur at any age. This is characterized by increased vulnerability to stressors resulting from deficits in multiple physiologic systems, i.e., the immune, musculoskeletal, endocrine, and neurologic systems [3]. …
Literatur
1.
Zurück zum Zitat Vaupel JW, Manton KG, Stallard E. The impact of heterogeneity in individual frailty on the dynamics of mortality. Demography. 1979;16:439–454CrossRef Vaupel JW, Manton KG, Stallard E. The impact of heterogeneity in individual frailty on the dynamics of mortality. Demography. 1979;16:439–454CrossRef
2.
Zurück zum Zitat Rockwood K, Stadnyk K, MacKnight C. A brief clinical instrument to classify frailty in elderly people. Lancet. 1999;353:205–206CrossRef Rockwood K, Stadnyk K, MacKnight C. A brief clinical instrument to classify frailty in elderly people. Lancet. 1999;353:205–206CrossRef
3.
Zurück zum Zitat Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752–762CrossRef Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752–762CrossRef
4.
Zurück zum Zitat Thompson C, Taleban S. Incorporating frailty in the treatment program of elderly patients with gastrointestinal disease. Curr Treat Options Gastroenterol. 2020;18:635–656CrossRef Thompson C, Taleban S. Incorporating frailty in the treatment program of elderly patients with gastrointestinal disease. Curr Treat Options Gastroenterol. 2020;18:635–656CrossRef
5.
Zurück zum Zitat Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019;94:155–165CrossRef Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019;94:155–165CrossRef
6.
Zurück zum Zitat Asscher V, Meijer L, Waars S, Slagboom J, Van der Meulen- de Jong A, Mooijaart S, et al. P732 Disability in older IBD patients. J Crohn’s Colitis. 2018;12:S481–S482. Asscher V, Meijer L, Waars S, Slagboom J, Van der Meulen- de Jong A, Mooijaart S, et al. P732 Disability in older IBD patients. J Crohn’s Colitis. 2018;12:S481–S482.
7.
Zurück zum Zitat Kochar B, Cai W, Cagan A, Ananthakrishnan AN. Frailty is independently associated with mortality in 11 001 patients with inflammatory bowel diseases. Aliment PharmacolTher. 2020;52:311–318CrossRef Kochar B, Cai W, Cagan A, Ananthakrishnan AN. Frailty is independently associated with mortality in 11 001 patients with inflammatory bowel diseases. Aliment PharmacolTher. 2020;52:311–318CrossRef
8.
Zurück zum Zitat Kochar B, Cai W, Cagan A, Ananthakrishnan AN. Pretreatment frailty is independently associated with increased risk of infections after immunosuppression in patients with inflammatory bowel diseases. Gastroenterology. 2020;158:2104–2111CrossRef Kochar B, Cai W, Cagan A, Ananthakrishnan AN. Pretreatment frailty is independently associated with increased risk of infections after immunosuppression in patients with inflammatory bowel diseases. Gastroenterology. 2020;158:2104–2111CrossRef
9.
Zurück zum Zitat Qian AS, Nguyen NH, Elia J, Ohno-Machado L, Sandborn WJ, Singh S. Frailty is independently associated with mortality and readmission in hospitalized patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2020;S1542–3565(20)31119–8. [Epub ahead of print]. Qian AS, Nguyen NH, Elia J, Ohno-Machado L, Sandborn WJ, Singh S. Frailty is independently associated with mortality and readmission in hospitalized patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2020;S1542–3565(20)31119–8. [Epub ahead of print].
10.
Zurück zum Zitat Faye AS, Wen T, Soroush A, Ananthakrishnan AN, Ungaro R, Lawlor G, et al. Increasing prevalence of frailty and its association with readmission and mortality among hospitalized patients with IBD. Dig Dis Sci. (Epub ahead of print). doi: https://doi.org/10.1007/s10620-020-06746-w. Faye AS, Wen T, Soroush A, Ananthakrishnan AN, Ungaro R, Lawlor G, et al. Increasing prevalence of frailty and its association with readmission and mortality among hospitalized patients with IBD. Dig Dis Sci. (Epub ahead of print). doi: https://​doi.​org/​10.​1007/​s10620-020-06746-w.
Metadaten
Titel
Frailty, Thy Diagnosis Is Uncertain: Impact on IBD Readmission and Mortality
verfasst von
Simon J. Hong
Seymour Katz
Publikationsdatum
22.03.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 12/2021
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-06926-2

Weitere Artikel der Ausgabe 12/2021

Digestive Diseases and Sciences 12/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.